Sickle cell disease is often thought of solely as a blood disorder, but new research from the Wood Neuro Research Group ...

Nemours Children's Hospital is now offering Lyfgenia gene therapy. The treatment aims to reduce pain crises and hospital visits for young patients.

Contrary to misconceptions among medical professionals and patients alike, individuals born with sickle cell trait (SCT) show no risk of experiencing the acute pain crises known to occur with sickle ...

Makenzie’s first sickle cell pain crisis came without warning. She was scared and felt alone. Not only was the pain excruciating, but her parents weren’t there—her two worst fears at once. She spent ...

RICHMOND, Va. — September is National Sickle Cell Awareness Month. Sickle cell affects 100,000 people in the United States, primarily impacting African Americans. To learn more about the genetic blood ...

Sickle cell disease advocates in East Texas say raising awareness and expanding education are critical steps toward improving care and saving lives. Despite being the most common inherited blood ...

Please provide your email address to receive an email when new articles are posted on . Researchers observed what they called “alarming” underutilization of disease-modifying therapies for sickle cell ...

Deshawn "DJ" Chow is one of just over 100 sickle cell patients who have undergone treatment with new gene therapies. CVS Health CEO David Joyner said private insurers and employer-sponsored health ...